Shandong Weigao Group Medical Polymer Company Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SHWGF research report →
About the company
Shandong Weigao Group Medical Polymer Company Limited, established in Weihai, People's Republic of China, in 2000, operates as a comprehensive entity focused on the research, development, manufacturing, and sale of a wide array of medical devices, primarily single-use, across the PRC. The company's operations are structured into several distinct segments, including Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, and Blood Management Products. Its extensive product portfolio includes essential medical consumables such as infusion devices for both vascular and non-vascular access, infusion sets, syringes, puncture needles, and specialized clinical collection kits.
- CEO
- Rinan Cong
- IPO
- 2010
- Employees
- 12,719
- HQ
- Weihai, CN
Price Chart
- Market Cap
- $1.91B
- P/E
- 8.13
- P/S
- 0.94
- P/B
- 0.54
- EV/EBITDA
- 3.46
- Div Yield
- 5.37%
- Gross Margin
- 47.26%
- Op Margin
- 12.69%
- Net Margin
- 12.04%
- ROE
- 6.69%
- ROIC
- 4.60%
- Revenue
- $13.04B · -0.33%
- Net Income
- $1.57B · -24.00%
- EPS
- $0.35 · -23.91%
- Op Income
- $1.83B
- FCF YoY
- -19.82%
- 52W High
- $0.76
- 52W Low
- $0.43
- 50D MA
- $0.44
- 200D MA
- $0.62
- Beta
- 0.35
- Avg Volume
- 1.01K
Get TickerSpark's AI analysis on SHWGF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SHWGF coverage
Recent articles, reports, and earnings notes.
No research on SHWGF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SHWGF report →Similar companies
Peers in the same neighborhood.